Hospitals Cry Foul After Eli Lilly Withholds 340B Discounts
Katie Adams / medcitynews - Eli Lilly made good on its threat to withhold 340B drug discounts from hospitals that refused to submit claims data. Hospital groups are calling the policy unlawful, arguing that the company has no legal authority to create its own compliance requirements…
AI Summary: Eli Lilly has begun denying 340B program discounts to participating hospitals after issuing an ultimatum, prompting sharp criticism from safety-net providers. Hospitals say the move will squeeze margins and threaten patient access to affordable medicines. The dispute centers on manufacturer discount eligibility and contract terms as providers scramble to quantify the financial hit.
- Federal 340B reforms and CMS payment proposals (3)
- Hospitals protest Lilly denying 340B discounts (4)
- Legal rulings and stakeholder reactions to 340B fight (3)
Federal 340B reforms and CMS payment proposals
Hospitals protest Lilly denying 340B discounts
Legal rulings and stakeholder reactions to 340B fight
Related Stories
Tampa General sues Eli Lilly over pulled 340B discounts / 10 hrs
Eli Lilly demands 340B claims data or cuts hospitals off / 5 wks
340B discounts face reform as profits outpace patient benefit / 2 months
AbbVie sues HHS over 340B patient definition and guidance / 3 months
Hospitals push regulators to block expanded 340B claims reporting requirements / 4 months
CVS sues Tennessee over PBM‑pharmacy separation law / 6 wks
Thousands of Medicare beneficiaries unexpectedly lose 'free' drug plans / 10 hrs
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Research Funding, Government Policy, Cybersecurity, Behavioral Health and look for the RSS link.
StackHealth Time Machine